BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2025.
World J Clin Oncol. Dec 24, 2025; 16(12): 112626
Published online Dec 24, 2025. doi: 10.5306/wjco.v16.i12.112626
Table 2 Univariate and multivariate survival analyses for association between clinicopathological parameters and YY1 expression
ParameterUnivariate analysis
Multivariate analysis
HR (95%CI)
P value
HR (95%CI)
P value
Gender (male vs female)1.036 (0.592-1.815)0.901--
Age (< 60 years vs ≥ 60 years)0.882 (0.496-1.567)0.668--
Tumor location (upper vs middle + lower)0.837 (0.478-1.467)0.535--
Tumor size (< 6 cm vs ≥ 6 cm)1.344 (0.820-2.202)0.241--
Differentiation (well + moderate vs poor + undifferentiated)3.338 (1.744-6.387)< 0.0012.152 (1.108-4.181)0.024
pT stage (T1-T2 vs T3-T4)4.821 (2.292-10.138)< 0.0012.568 (1.169-5.642)0.019
Lymph node metastasis (absent vs present)4.682 (2.378-9.219)< 0.0013.067 (1.493-6.300)0.002
pTNM stage (I-II vs III-IV)3.818 (2.330-6.255)< 0.0012.211 (1.306-3.724)0.003
YY1 expression (low vs high)1.966 (1.106-3.495)0.0211.315 (1.054-1.552)0.045


Write to the Help Desk